Breaking News Instant updates and real-time market news.

FFIV

F5 Networks

$164.24

0.3 (0.18%)

16:16
04/24/19
04/24
16:16
04/24/19
16:16

F5 Networks reports Q2 adjusted EPS 2.57, consensus $2.54

Reports Q2 revenue $544.9M, consensus $547.15M.

  • 24

    Apr

FFIV F5 Networks
$164.24

0.3 (0.18%)

03/29/19
03/29/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) upgraded to Market Perform from Underperform at Raymond James with analyst David Long saying the retirement of CEO Tim Sloan removes a "headwind." 2. Viacom (VIA, VIAB) upgraded to Buy from Hold at Loop Capital with analyst Alan Gould citing the company's loss of its biggest distributor AT&T (T) having been de-risked which, he believes, raises the likelihood of a Viacom merger with CBS (CBS). 3. F5 Networks (FFIV) upgraded to Neutral from Underweight at Piper Jaffray with analyst James Fish saying after underperforming the tech sector and the market over the last six months by ~20%, some of the main downside share catalysts have played out. 4. Mosaic (MOS) upgraded to Neutral from Underperform at Credit Suisse with analyst Chris Parkinson citing modest downside to Chinese cash operating costs, lower immediate-term ammonia and sulfur costs, evidence of near-term volume discipline, the emphasis on long-term cost reduction programs and balance sheet stability. 5. KeyCorp (KEY) upgraded to Neutral from Reduce at Nomura Instinet with analyst Bill Carcache saying he believes the shares are near a fair valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/01/19
NOMU
04/01/19
UPGRADE
Target $180
NOMU
Buy
F5 Networks upgraded to Buy from Neutral at Nomura Instinet
Nomura Instinet analyst Jeffrey Kvaal upgraded F5 Networks to Buy from Neutral and raised his price target for the shares to $180 from $155.
04/01/19
NOMU
04/01/19
UPGRADE
Target $180
NOMU
Buy
Nomura Instinet upgrades F5 to Buy, says security story resonating
Nomura Instinet analyst Jeffrey Kvaal upgraded F5 Networks to Buy from Neutral and raised his price target for the shares to $180 from $155. "Long an out-of-favor name," F5 shares are now ~25% below their 2018 peak following the acquisition of Nginx, Kvaal tells investors in a research note. However, the analyst's work indicates the company's "security story is resonating," physical application delivery controller revenue declines are contained, and that new launches should boost F5's share in virtual ADCs. He believes the company's "rapidly rising mix of software" will allow its multiple to rise.
04/01/19
04/01/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. UPS (UPS) upgraded to Buy from Hold at Berenberg with analyst Joel Spungin saying he is increasingly confident that UPS will deliver margin improvement in both its International business and the U.S. this year, following an in-depth review of European parcel markets. 2. AstraZeneca (AZN) upgraded to Outperform from Market Perform at Cowen with analyst Steve Scala saying the 5% stock decline on news of the company's partnership with Daiichi Sankyo for trastuzumab deruxtecan, which he calls a "promising" breast cancer drug, offers a compelling entry point. 3. Energizer (ENR) upgraded to Conviction Buy from Neutral at Goldman Sachs with analyst Jason English saying he sees a credible path to top-tier EBIT, EBITDA and EPS growth over the next three years "fueled almost entirely" by debt-reduction and synergies from its recently completed deals for the Global Battery & Lighting business and Global Auto Care business of Spectrum Brands (SPB). 4. Anadarko (APC) resumed with a Buy from Neutral at Citi with analyst Robert Morris citing the stock's underperformance over the past three months and the company's recent success in the Delaware Basin for the upgrade. 5. F5 Networks (FFIV) upgraded to Buy from Neutral at Nomura Instinet with analyst Jeffrey Kvaal saying "long an out-of-favor name," F5 shares are now ~25% below their 2018 peak following the acquisition of Nginx. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

, LLL

L3 Technologies

$256.30

(0.00%)

17:18
06/24/19
06/24
17:18
06/24/19
17:18
Hot Stocks
MarketAxess to replace L3 Technologies in S&P 500 at open on 7/1 »

Harris (HRS) is acquiring…

MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

LLL

L3 Technologies

$256.30

(0.00%)

HRS

Harris

$197.28

-0.07 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VGZ

Vista Gold

$0.81

-0.0026 (-0.32%)

17:04
06/24/19
06/24
17:04
06/24/19
17:04
Hot Stocks
Vista Gold CFO Jack Engele to retire, Douglas Tobler to succeed »

Vista Gold is pleased to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$198.60

-0.17 (-0.09%)

17:03
06/24/19
06/24
17:03
06/24/19
17:03
Periodicals
Apple to announce Seattle expansion on Monday, Seattle Times reports »

According to a story by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPE

HP Enterprise

$15.00

0.07 (0.47%)

, CRWD

Crowdstrike

$67.91

-5.09 (-6.97%)

17:01
06/24/19
06/24
17:01
06/24/19
17:01
Hot Stocks
HP Enterprise appoints Crowdstrike CEO George Kurtz to Board of Directors »

Hewlett Packard…

HPE

HP Enterprise

$15.00

0.07 (0.47%)

CRWD

Crowdstrike

$67.91

-5.09 (-6.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

  • 09

    Jul

NGM

NGM Biopharmaceuticals

$13.88

0.1 (0.73%)

17:01
06/24/19
06/24
17:01
06/24/19
17:01
Initiation
NGM Biopharmaceuticals initiated  »

NGM Biopharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNDA

Vanda Pharmaceuticals

$13.81

-0.27 (-1.92%)

17:00
06/24/19
06/24
17:00
06/24/19
17:00
Hot Stocks
Armistice Capital reports 6.2% passive stake in Vanda Pharmaceuticals »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

CBAY

CymaBay

$6.76

-0.32 (-4.52%)

16:58
06/24/19
06/24
16:58
06/24/19
16:58
Initiation
CymaBay initiated  »

CymaBay initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PK

Park Hotels & Resorts

$27.47

-0.73 (-2.59%)

16:58
06/24/19
06/24
16:58
06/24/19
16:58
Hot Stocks
Park Hotels & Resorts announces sale of three non-core assets for $166M »

Park Hotels & Resorts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICPT

Intercept

$79.64

-1.74 (-2.14%)

16:56
06/24/19
06/24
16:56
06/24/19
16:56
Initiation
Intercept initiated  »

Intercept initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRYS

Krystal Biotech

$41.15

11.87 (40.54%)

16:48
06/24/19
06/24
16:48
06/24/19
16:48
Syndicate
Krystal Biotech files to sell $100M of common stock »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

GNFT

Genfit

$20.19

-0.02 (-0.10%)

16:40
06/24/19
06/24
16:40
06/24/19
16:40
Hot Stocks
Breaking Hot Stocks news story on Genfit »

Genfit SA (ADS) trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:40
06/24/19
06/24
16:40
06/24/19
16:40
General news
Fed's Kaplan wants to take more of a wait-and-see approach to policy »

Fed's Kaplan wants…

CHWY

Chewy

$31.52

-0.64 (-1.99%)

16:38
06/24/19
06/24
16:38
06/24/19
16:38
Hot Stocks
Lone Pine Capital reports 6.1% passive stake in Chewy »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARQL

ArQule

$10.00

-0.48 (-4.58%)

16:38
06/24/19
06/24
16:38
06/24/19
16:38
Syndicate
ArQule files to sell common stock, no amount given »

SVB Leerink and RBC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLXT

Calyxt

$12.55

-0.43 (-3.31%)

16:35
06/24/19
06/24
16:35
06/24/19
16:35
Hot Stocks
Calyxt enters commercial crushing agreement with Landus Cooperative »

Calyxt announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

CNAT

Conatus

$0.94

0.0019 (0.20%)

16:35
06/24/19
06/24
16:35
06/24/19
16:35
Hot Stocks
Breaking Hot Stocks news story on Conatus 

Conatus trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

GNFT

Genfit

$20.19

-0.02 (-0.10%)

16:34
06/24/19
06/24
16:34
06/24/19
16:34
Hot Stocks
Terns announces licensing, collaboration agreement with Genfit »

Terns Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EHC

Encompass Health

$61.64

-0.305 (-0.49%)

16:34
06/24/19
06/24
16:34
06/24/19
16:34
Hot Stocks
Encompass Health makes investment in Medalogix »

Encompass Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHS

Chico's

$3.33

-0.065 (-1.92%)

16:32
06/24/19
06/24
16:32
06/24/19
16:32
Hot Stocks
Chico's FAS board approves amendment to company bylaws over share acquisition »

Chico's FAS issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBNK

Territorial Bancorp

$27.87

-0.12 (-0.43%)

16:31
06/24/19
06/24
16:31
06/24/19
16:31
Hot Stocks
Territorial Bancorp declares special mid-year cash dividend of 10c per share »

Payable on July 22 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARQL

ArQule

$10.00

-0.48 (-4.58%)

16:31
06/24/19
06/24
16:31
06/24/19
16:31
Syndicate
Breaking Syndicate news story on ArQule »

ArQule files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COST

Costco

$266.83

0.58 (0.22%)

16:30
06/24/19
06/24
16:30
06/24/19
16:30
Hot Stocks
Costco VP Roland Michael Vachris sells almost $1M in company shares »

Costco VP Roland Michael…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

  • 03

    Oct

16:30
06/24/19
06/24
16:30
06/24/19
16:30
Options
Preliminary option volume of 15.3M today »

Preliminary option volume…

EB

Eventbrite

$16.07

-0.23 (-1.41%)

16:28
06/24/19
06/24
16:28
06/24/19
16:28
Hot Stocks
Foxhaven Asset Management reports 5.8% passive stake in Eventbrite »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRTA

Forterra

$4.56

-0.04 (-0.87%)

16:27
06/24/19
06/24
16:27
06/24/19
16:27
Hot Stocks
Forterra sees FY19 results 'in line with its prior guidance' »

The company continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.